Study mail-order pharmacy use urged

Summary#

Senate Resolution 102 (SR-102) urges Hawaii’s Insurance Commissioner to study possible benefits of expanding mail-order pharmacy use; it does not amend a statute or itself expand the use of mail-order prescriptions. Its stated goal is to give the Legislature information about possible effects on patients, costs, access, and pharmacies. The supplied material says it was enacted, but its key actions are worded as requests and urges.

  • The Commissioner is urged to study mail-order pharmacy and requested to report findings, recommendations, and any proposed legislation to the Legislature no later than 20 days before the 2027 regular session.
  • The study is urged to cover medication adherence and chronic disease; possible savings; access for kupuna, rural residents, and people with disabilities or limited mobility; and shipping safety and reliability.
  • It is also urged to consider emergency access, ways patients who prefer mail order could choose it through their prescription benefits, and effects on community pharmacies and rural access to local pharmacies.
  • State and county agencies are urged to cooperate with the Commissioner’s requests for data and other assistance.

What it means for you#

  • Patients and the public: The resolution does not require pharmacies or insurers to expand mail-order services, change prescription benefits, or make patients use mail order. It asks for a study of potential benefits and impacts.
  • Kupuna, rural residents, and people with disabilities or limited mobility: Their access is among the study topics. The resolution does not create a new service or guarantee delivery.
  • Insurance Commissioner and state and county agencies: The Commissioner is asked to study and report; agencies are urged to assist. The resolution does not set out a study method or require a particular recommendation.

Money#

No cost information is in the available material.

  • The resolution gives no estimate for the study or the staff and data work it may involve.
  • It does not appropriate money or set new fees, benefits, or payments.

What is unclear#

  • The resolution does not say how the study must be carried out, what data it must use, or how its findings should be assessed.
  • It does not specify funding, staffing, or whether the Commissioner will complete the requested study and report.
  • It does not define “mail-order pharmacy” or say which medicines or patients the study should cover.
  • It does not set out how patients could select mail order through prescription benefits; that is a topic for study, not a new choice right created by the resolution.

Case for#

  • A study could give lawmakers information before they consider changing prescription benefits or other policy.
  • Looking at adherence, costs, delivery safety, and emergency access together could help identify both potential benefits and risks.
  • Including effects on community pharmacies and rural access could help assess whether expanded mail-order use might affect local pharmacy services.

Case against#

  • The resolution does not require the study or agency cooperation, so it may not produce the requested findings by the stated deadline.
  • It sets no method, funding, or standards for judging costs and health effects, which could limit how useful or comparable the results are.
  • A study alone does not improve access or lower costs; any service or policy changes would require further action.

Votes

The recorded vote on this bill, member by member.

  1. Division No. 1677926

    Passed4 members voted

    Senate Commerce and Consumer Protection: Passed, With Amendments

    FOR · 4

    Each dot is one member. Hover or tap one to see who.

    4For

    • Democratic4

    0Against

    1 member was paired and sat out the vote.